D1000VFARMA (DMVF3) Main Indicators
Basic Data - DMVF3
| Company | D1000VFARMA |
| Corporate Name | D1000 VAREJO FARMA PARTICIPAÇÕES S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | A Companhia tem por objeto a participação. como sócia ou acionista. em outras sociedades do varejo farmacêutico. nacionais ou estrangeiras. |
| Share | DMVF3 |
| Quote Date | 04/01/2025 |
| Share Type | ON |
| Last Closing | R$ 5.49 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 422.70 thousand |
| Last Statement | DFP - 12/31/2024 |
| Sector | Saúde |
| Subsector | Comércio e Distribuição |
| Segment | Medicamentos e Outros Produtos |
| Participation Indexes | IGC, IGNM, ITAG |
| Updated 04/02/2025 | |
Relative Prices - DMVF3
| Price/Earnings | 10.74 |
| Price/SBV | 0.31 |
| Price/Net Sales | 0.13 |
| Price/CFO | 1.57 |
| Price/FCF | 2.80 |
| Price/Total Assets | 0.15 |
| Price/EBIT | 4.39 |
| Price/Working Capital | 3.76 |
| Price/NCAV | -0.32 |
| EV/EBIT | 4.10 |
| EV/EBITDA | 1.43 |
| EV/Net Sales | 0.12 |
| EV/CFO | 1.47 |
| EV/FCF | 2.61 |
| EV/Total Assets | 0.14 |
| Company Market Cap | R$ 277.81 M |
| Enterprise Value | R$ 259.08 M |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 5.49 |
| Share Price Date | 04/01/2025 |
| Dividend Yield | 0.00% |
| Updated 04/02/2025 | |
Income Statement - DMVF3
| Net Revenue | R$ 2.16 B |
| Gross Result | R$ 661.64 M |
| EBIT | R$ 63.24 M |
| Depreciation and Amortization | - R$ 117.65 M |
| EBITDA | R$ 180.88 M |
| Net Profit | R$ 25.86 M |
| Net Profit/Share | R$ 0.51 |
| Updated 03/12/2025 | |
| Net Revenue | R$ 621.19 M |
| Gross Result | R$ 173.71 M |
| EBIT | R$ 10.92 M |
| Depreciation and Amortization | - R$ 31.46 M |
| EBITDA | R$ 42.38 M |
| Net Profit | R$ 3.50 M |
| Profit/Share | R$ 0.07 |
| Updated 03/12/2025 | |
Price and Volume Behavior - DMVF3
| Lowest Price 52 weeks | R$ 5.08 |
| Highest Price 52 weeks | R$ 8.38 |
| Variation 2025 | -3.51% |
| Variation 1 year | -17.32% |
| Variation 2 years(total) | 59.59% |
| Variation 2 years(yearly) | 26.25% |
| Variation 3 years(total) | 19.61% |
| Variation 3 years(yearly) | 6.14% |
| Variation 4 years(total) | -39.34% |
| Variation 4 years(yearly) | -11.74% |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 411.69 thousand |
| Updated 04/02/2025 | |
Returns and Margins - DMVF3
| Return on Initial Tangible Capital | 8.26% |
| Return on Initial Invested Capital | 4.89% |
| Pre-Tax Return on Initial Tangible Capital | 12.51% |
| Pre-Tax Return on Initial Invested Capital | 7.41% |
| Return on Initial Shareholder´s Equity | 2.97% |
| Return on Initial Asset | 1.67% |
| Gross Margin | 30.62% |
| Net Margin | 1.20% |
| EBIT Margin | 2.93% |
| EBITDA Margin | 8.37% |
| Initial Asset Turnover | 1.40 |
| Financial Leverage | 2.05 |
| Liabilities/Net Worth | 1.05 |
| Net Debt/EBITDA | -0.10 |
| Updated 03/12/2025 | |
Balance Sheet - DMVF3
| Cash and Cash Equivalents | R$ 57.60 M |
| Total Assets | R$ 1.83 B |
| Short-Term Debt | R$ 10.66 M |
| Long-Term Debt | R$ 28.21 M |
| Gross Debt | R$ 38.87 M |
| Net Debt | - R$ 18.73 M |
| Shareholder´s Equity | R$ 896.71 M |
| Share Book Value | R$ 17.72 |
| Common Shares | 50,603,000 |
| Preferred Shares | 0 |
| Total | 50,603,000 |
| Common Shares in Treasury | 0 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 0 |
| Common Shares (Except Treasury) | 50,603,000 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 50,603,000 |
| Updated 03/12/2025 | |
Cash Flow - DMVF3
| Operating Cash Flow | R$ 176.74 M |
| Cash Flow from Investments | - R$ 94.81 M |
| Financing Cash Flow | - R$ 68.56 M |
| Increase (Reduction) in Cash and Equivalents | R$ 13.37 M |
| Updated 03/12/2025 | |
| Operating Cash Flow | R$ 53.70 M |
| Cash Flow from Investments | - R$ 34.63 M |
| Financing Cash Flow | - R$ 680.00 thousand |
| Increase (Reduction) in Cash and Equivalents | R$ 18.39 M |
| Updated 03/12/2025 | |
Experimental - DMVF3
| CAPEX 3 months | - R$ 32.50 M |
| Free Cash Flow 3 months | R$ 21.20 M |
| CAPEX 12 months | - R$ 77.48 M |
| Free Cash Flow 12 months | R$ 99.26 M |
| Updated 03/12/2025 | |